fig1
From: Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
Figure 1. Schematic diagram of the spectrum of NAFLD to NAFLD-associated HCC and the clinical factors implicated in its pathogenesis or prevention. NAFLD: nonalcoholic fatty liver disease; HCC: hepatocellular carcinoma; ASA: aspirin
